IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 109 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,633,528 | -13.4% | 89,278 | 0.0% | 0.50% | -11.3% |
| Q2 2023 | $5,353,109 | -14.2% | 89,278 | -32.0% | 0.56% | -17.7% |
| Q1 2023 | $6,238,806 | -27.1% | 131,288 | -12.5% | 0.68% | -23.3% |
| Q4 2022 | $8,560,500 | -0.1% | 150,000 | 0.0% | 0.89% | -0.4% |
| Q3 2022 | $8,571,000 | +64.1% | 150,000 | +7.1% | 0.90% | +51.3% |
| Q2 2022 | $5,223,000 | +2.5% | 140,000 | -17.9% | 0.59% | +17.9% |
| Q1 2022 | $5,097,000 | +66.1% | 170,472 | +89.4% | 0.50% | +146.6% |
| Q4 2021 | $3,069,000 | -8.0% | 90,000 | 0.0% | 0.20% | -12.8% |
| Q3 2021 | $3,336,000 | -5.1% | 90,000 | 0.0% | 0.23% | -2.1% |
| Q2 2021 | $3,515,000 | – | 90,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $28,523,073 | 25.19% |
| Velan Capital Investment Management LP | 200,000 | $9,888,000 | 8.43% |
| RTW INVESTMENTS, LP | 5,649,943 | $279,333,182 | 5.82% |
| Paradigm Biocapital Advisors LP | 1,126,256 | $55,682,097 | 5.28% |
| Rock Springs Capital Management LP | 3,001,662 | $148,402,169 | 3.54% |
| Logos Global Management LP | 500,000 | $24,720,000 | 3.54% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $20,052,864 | 2.99% |
| GREAT POINT PARTNERS LLC | 255,367 | $12,625,344 | 2.48% |
| COWEN AND COMPANY, LLC | 405,174 | $20,031,802 | 2.35% |
| Eschler Asset Management LLP | 60,000 | $2,966,400 | 2.34% |